BIO

Bio-Rad Laboratories, Inc.

$386.48

-0.47%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories.

Source: Yahoo Finance
AI summary

Price & performance

1M-2.8%
3M+6.1%
YTD+20.9%
1Y+19.0%
52-week range—
Beta0.92
Full chart and returns against a benchmark

Q-Score

60/ 100

Quality against peers; 50 is the peer median.

Growth44
Risk73
Performance53
Valuation58
Profitability58
Leverage60
Sentiment40
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$2.6B+0.7%
Net income$759.9M
Net margin29.4%+101.3 pts
Historical fundamentals

Revenue exposure

60%of revenue from outside the US
United States40%
Europe34%
Asia Pacific20%
Regions, segments, customers and suppliers

Valuation

BIOIndustryP/E10.1629.61P/S4.013.49EV/EBITDA103.6718.38P/B1.373.39PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Nov 4next report
EPS estimate$2.23
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate